v3.25.3
Condensed Consolidated Statements of Cash Flows (unaudited) - USD ($)
$ in Millions
6 Months Ended
Sep. 30, 2025
Sep. 30, 2024
OPERATING ACTIVITIES    
Net income $ 259 $ 279
Adjustments to determine net cash provided by operating activities:    
Depreciation and amortization 300 281
Loss (gain) on unrealized derivatives and other realized derivatives in investing activities, net 38 (46)
Loss on sale or disposal of assets, net 3 2
Non-cash restructuring and impairment charges 69 33
Loss on extinguishment of debt, net 3 0
Deferred income taxes, net 22 0
Equity in net income of non-consolidated affiliates (6) (3)
Loss on foreign exchange remeasurement of debt 18 15
Amortization of debt issuance costs and carrying value adjustments 8 6
Non-cash charges related to Sierre flooding 0 42
Non-cash charges related to Oswego fire 11 0
Other, net 0 2
Changes in assets and liabilities including assets and liabilities held for sale:    
Accounts receivable 105 (202)
Inventories (251) (289)
Accounts payable (61) 341
Other assets (21) 21
Other liabilities (86) (108)
Net cash provided by operating activities 411 374
INVESTING ACTIVITIES    
Capital expenditures (913) (717)
Outflows from investment in and advances to non-consolidated affiliates, net (3) (7)
Outflows from the settlement of derivative instruments, net (17) (1)
Proceeds from insurance claims 18 0
Other 5 6
Net cash used in investing activities (910) (719)
FINANCING ACTIVITIES    
Proceeds from issuance of long-term and short-term borrowings 1,378 64
Principal payments of long-term and short-term borrowings (817) (68)
Revolving credit facilities and other, net 99 106
Debt issuance costs (23) 0
Return of capital to our common shareholder (35) 0
Net cash provided by financing activities 602 102
Net increase (decrease) in cash, cash equivalents and restricted cash 103 (243)
Effect of exchange rate changes on cash 18 2
Cash, cash equivalents and restricted cash – beginning of period 1,041 1,322
Cash, cash equivalents and restricted cash – end of period 1,162 1,081
Supplemental Disclosures:    
Accrued capital expenditures $ 301 $ 250

Source